Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Issued Shares Outstanding Shares Outstanding

Treace Medical Concepts (TMCI) Shares Issued (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Shares Issued readings, the most recent being -$476000.0 for Q4 2025.

On a quarterly basis, Shares Issued fell 935.09% to -$476000.0 in Q4 2025 year-over-year; TTM through Sep 2025 was $533000.0, a 2.91% decrease, with the full-year FY2024 number at $428000.0, down 77.1% from a year prior.
Shares Issued hit -$476000.0 in Q4 2025 for Treace Medical Concepts, down from $241000.0 in the prior quarter.
In the past five years, Shares Issued ranged from a high of $107.5 million in Q1 2023 to a low of -$105.8 million in Q3 2023.
Median Shares Issued over the past 5 years was $148500.0 (2023), compared with a mean of $394625.0.
Biggest five-year swings in Shares Issued: plummeted 32849.23% in 2021 and later surged 2912.5% in 2025.
Treace Medical Concepts' Shares Issued stood at -$105.8 million in 2021, then skyrocketed by 102.07% to $2.2 million in 2022, then tumbled by 91.86% to $178000.0 in 2023, then plummeted by 67.98% to $57000.0 in 2024, then crashed by 935.09% to -$476000.0 in 2025.
The last three reported values for Shares Issued were -$476000.0 (Q4 2025), $241000.0 (Q3 2025), and $116000.0 (Q2 2025) per Business Quant data.